Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthitis (o-JIA); association of MIF promoter polymorphisms with response to intra-articular glucocorticoids

Clinical and Experimental Rheumatology

Volumn 25, Issue 5, 2007, Pages 775-781

  Vivarelli, Marina ^a   D'Urbano, Leila E ^a   Insalaco, Antonella ^a   Lunt, Mark ^b   Jury, Francine ^b   Tozzi, Alberto E ^a   Ravelli, Angelo ^c   Martini, Alberto ^c   Donn, Rachelle ^b   De Benedetti, Fabrizio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Arthritis; Glucocorticoid; MIF; Polymorphism

Indexed keywords

GLUCOCORTICOID; MACROPHAGE MIGRATION INHIBITION FACTOR; TRIAMCINOLONE HEXACETONIDE;

ALLELE; ARTICLE; CAPILLARY ELECTROPHORESIS; CAUCASIAN; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; IRIDOCYCLITIS; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RELAPSE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; ALLELES; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INFANT; INJECTIONS, INTRA-ARTICULAR; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; OUTCOME ASSESSMENT (HEALTH CARE); POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS (GENETICS); RETROSPECTIVE STUDIES; SYNOVIAL FLUID; TREATMENT OUTCOME;

EID: 37349075475     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ANSELL BM: Rheumatic disorders in childhood. London, Boston, Butterworths, 1980.
2. SCHNEIDER R, PASSO MH: Juvenile rheumatoid arthritis. Rheum Dis Clin North Am 2002; 28: 503-30.
3. PETTY RE, SOUTHWOOD TR, BAUM J et al.: Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991-4.
4. GUILLAUME S, PRIEUR AM, COSTE J, JOB-DESLANDRE C: Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 2000; 43: 1858-65.
5. DE BENEDETTI F, RAVELLI A, MARTINI A: Cytokines in juvenile rheumatoid arthritis. Curr Opin Rheumatol 1997; 9: 428-33.
6. CLEARY AG, MURPHY HD, DAVIDSON JE: Intra-articular corticosteroid injections in juvenile idiopathic arthritis. Arch Dis Child 2003; 88: 192-6.
7. CALANDRA T, ROGER T: Macrophage miAration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3: 791-800.
8. MORAND EF: New therapeutic target in inflaMmatory disease: macrophage migration inhibitory factor. Intern Med J 2005; 35: 419-26.
9. LUE H, KLEEMANN R, CALANDRA T, ROGER T, BERNHAGEN J: Macrophage migration inhibitory factor (MIF): Mechanisms of action and role in disease. Microbes Infect 2002; 4: 449-60.
10. RENNER P, ROGER T, CALANDRA T: Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 2005; 41 (Suppl. 7): S513-9.
11. DONN RP, RAY DW: Macrophage migratMon inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 2004; 182: 1-9.
12. CALANDRA T, BERNHAGEN J, METZ CN et al.: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377: 68-71.
13. BACHER M, METZ CN, CALANDRA T et al.: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996; 93: 7849-54.
14. CALANDRA T, ECHTENACHER B, ROY DL et al.: Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164-70.
15. SANTOS L, HALL P, METZ C, BUCALA R, MORAND EF: Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol 2001; 123: 309-14.
16. ROGER T, CHANSON AL, KNAUP-REYMOND M, CALANDRA T: Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol 2005; 35: 3405-13.
17. LEECH M, METZ C, HALL P et al.: Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999; 42: 1601-8.
18. SAMPEY AV, HALL PH, MITCHELL RA, METZ CN, MORAND EF: Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 2001; 44: 1273-80.
19. ONODERA S, KANEDA K, MIZUE Y, KOYAMA Y, FUJINAGA M, NISHIHIRA J: Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000; 275: 444-50.
20. ONODERA S, NISHIHIRA J, KOYAMA Y et al.: Macrophage migration inhibitory factor upregulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: Common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta. Arthritis Rheum 2004; 50: 1437-47.
21. MIKULOWSKA A, METZ CN, BUCALA R, HOLMDAHL R: Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997; 158: 5514-7.
22. LEECH M, METZ C, SANTOS L et al.: Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998; 41: 910-7.
23. ICHIYAMA H, ONODERA S, NISHIHIRA J et al.: Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/ lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 2004; 26: 187-94.
24. GREGORY JL, LEECH MT, DAVID JR, YANG YH, DACUMOS A, HICKEY MJ: Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice. Arthritis Rheum 2004; 50: 3023-34.
25. MEAZZA C, TRAVAGLINO P, PIGNATTI P et al.: Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 232-7.
26. DONN R, ALOURFI Z, DE BENEDETTI F et al.: Mutation screening of the macrophage migration inhibitory factor gene: Positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2402-9.
27. RADSTAKE TR, SWEEP FC, WELSING P et al.: Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005; 52: 3020-9.
28. DE BENEDETTI F, MEAZZA C, VIVARELLI M et al.: Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003; 48: 1398-407.
29. RUPERTO N, RAVELLI A, PISTORIO A et al.: The Italian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001; 19 (Suppl. 23): S91-5.
30. RAVELLI A, MARTINI A: Remission in juvenile idiopathic arthritis. Clin Exp Rheumatol 2006; 24 (Suppl. 43): S105-10.
31. ZHONG XB, LENG L, BEITIN A et al.: Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res 2005; 33: E121.
32. DONN R, ALOURFI Z, ZEGGINI E et al.: A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004; 50: 1604-10.
33. MIZUE Y, GHANI S, LENG L et al.: Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci USA 2005; 102: 14410-5.
34. PLANT BJ, GALLAGHER CG, BUCALA R et al.: Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am J Respir Crit Care Med 2005; 172: 1412-5.
35. BAUGH JA, CHITNIS S, DONNELLY SC et al.: A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3: 170-6.
36. BARTON A, LAMB R, SYMMONS D et al.: Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 2003; 4: 487-91.
37. DONN RP, PLANT D, JURY F et al.: Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 2004; 123: 484-7.
38. EBERHARD B, GOTTLIEB BS, ILOWITE NT: Which dose to use for intraarticular steroid injection in juvenile arthritis. Arthritis Rheum 2003; 48: S91.
39. AL-ABED Y, DABIDEEN D, ALJABARI B et al.: ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 2005; 280: 36541-4.